Home > Boards > US OTC > Medical - Drugs > Creative Medical Technology Holdings, Inc. (CELZ)

The key players of stem cell exosome therapeutic

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
uplinkjim Member Profile
 
Followed By 6
Posts 409
Boards Moderated 0
Alias Born 10/26/09
160x600 placeholder
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 11/22/2019 4:50:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:49:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/5/2019 6:40:49 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 11/5/2019 4:59:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2019 4:03:28 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 9/13/2019 4:46:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 4:02:24 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 8/30/2019 4:02:45 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 4:49:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2019 12:33:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2019 4:02:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 11:34:57 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 11:32:16 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/28/2019 4:33:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 2:24:35 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/20/2019 2:27:14 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2019 4:48:52 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2019 5:27:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 6:44:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 4:08:03 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:42:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/5/2019 5:20:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2019 4:57:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/2/2019 8:02:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2018 5:05:38 PM
uplinkjim   Sunday, 10/20/19 09:11:25 AM
Re: None
Post # of 95790 
The key players of stem cell exosome therapeutic market include Evox Therapeutics, Capricor Therapeutics, Inc., Unicyte AG, Exogenus Therapeutics, Everkine Corporation, Creative Medical Technology Holdings Anjarium Biosciences, Kimera Labs, ReNeuron, Stem Cell Medicine Ltd., and Codiak Biosciences

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist